The Stryker InSpace™ Balloon Implant is a breakthrough treatment option for massive irreparable rotator cuff tears (MIRCTs). After 10 years of clinical research and 29,000 implants, the Stryker InSpace™ Balloon Implant was FDA-approved in July 2021. Dr. Stowell, one of the nation’s top fellowship-trained shoulder and elbow specialists, is able to perform this unique procedure! (Read JBJS Article)
InSpace is the industry’s only minimally invasive biodegradable, subacromial balloon spacer for arthroscopic treatment of massive, irreparable rotator cuff tears (MIRCTs)†. It is designed to restore the subacromial space without requiring sutures or fixation devices.
Rather than a total shoulder replacement or complex reconstruction, Dr. Stowell may be able to treat your chronic rotator cuff tear condition with this minimally invasive arthroscopic procedure using the Stryker InSpace Balloon implant. This innovative option takes the place of the rotator cuff, restoring the subacromial space, above the shoulder’s ball-and-socket joint where the rotator cuff is located. The balloon is biodegradable, dissolving over time, and clinically-proven to show improvement in shoulder function for two years. Patients can elect to repeat the procedure, if desired.
Typically, patients who are candidates for the InSpace Implant have MIRCT, are age 65 and older, and have muscle atrophy or ruptured rotator cuff tendons. Massive irreparable rotator cuff tears are typically characterized by a retracted tendon with chronic and significant limited mobility and muscle weakness. If Dr. Stowell treats your MIRCT condition with this arthroscopic, balloon implant procedure, he will make a tiny incision in your shoulder and insert the balloon to act as a cushion, which will reduce the friction in your shoulder that contributes to pain and ultimately, improve your shoulder’s range of motion.